Your browser doesn't support javascript.
loading
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.
El-Galaly, Tarec Christoffer; Cheah, Chan Yoon; Bendtsen, Mette Dahl; Nowakowski, Grzegorz S; Kansara, Roopesh; Savage, Kerry J; Connors, Joseph M; Sehn, Laurie H; Goldschmidt, Neta; Shaulov, Adir; Farooq, Umar; Link, Brian K; Ferreri, Andrés J M; Calimeri, Teresa; Cecchetti, Caterina; Dann, Eldad J; Thompson, Carrie A; Inbar, Tsofia; Maurer, Matthew J; Gade, Inger Lise; Juul, Maja Bech; Hansen, Jakob W; Holmberg, Staffan; Larsen, Thomas S; Cordua, Sabrina; Mikhaeel, N George; Hutchings, Martin; Seymour, John F; Clausen, Michael Roost; Smith, Daniel; Opat, Stephen; Gilbertson, Michael; Thanarajasingam, Gita; Villa, Diego.
Afiliação
  • El-Galaly TC; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark. Electronic address: tarec.galaly@gmail.com.
  • Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia.
  • Bendtsen MD; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
  • Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, USA.
  • Kansara R; Section of Medical Oncology and Hematology, Cancer Care Manitoba, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada; Division of Medical Oncology and Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Savage KJ; Division of Medical Oncology and Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Connors JM; Division of Medical Oncology and Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Sehn LH; Division of Medical Oncology and Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Goldschmidt N; Hematology Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Shaulov A; Hematology Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Farooq U; Division of Hematology, Oncology, Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, USA.
  • Link BK; Division of Hematology, Oncology, Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, USA.
  • Ferreri AJM; Unit of Lymphoid Malignancies, Department of OncoHematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Calimeri T; Unit of Lymphoid Malignancies, Department of OncoHematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cecchetti C; Unit of Lymphoid Malignancies, Department of OncoHematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Dann EJ; Rambam Health Care Campus, Haifa, Israel; Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Thompson CA; Division of Hematology, Mayo Clinic, Rochester, USA.
  • Inbar T; Rambam Health Care Campus, Haifa, Israel.
  • Maurer MJ; Department of Health Sciences Research, Mayo Clinic, Rochester, USA.
  • Gade IL; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
  • Juul MB; Department of Hematology, Vejle Hospital, Vejle, Denmark.
  • Hansen JW; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Holmberg S; Department of Hematology, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Larsen TS; Odense University Hospital, Odense, Denmark.
  • Cordua S; Department of Hematology, Zealand University Hospital, Denmark.
  • Mikhaeel NG; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, United Kingdom.
  • Hutchings M; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Seymour JF; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Clausen MR; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Smith D; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, United Kingdom.
  • Opat S; Monash Health and Monash University, Melbourne, Australia.
  • Gilbertson M; Monash Health and Monash University, Melbourne, Australia.
  • Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, USA.
  • Villa D; Division of Medical Oncology and Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
Eur J Cancer ; 93: 57-68, 2018 04.
Article em En | MEDLINE | ID: mdl-29477102
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Segunda Neoplasia Primária / Neoplasias do Sistema Nervoso Central / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Segunda Neoplasia Primária / Neoplasias do Sistema Nervoso Central / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2018 Tipo de documento: Article